Keep up-to-date with us

Category: Stakeholder

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

- 05/12/2025

Bridging gaps across the CLL care pathway – Part 2: Knowing When To Treat

- 20/11/2025

Bridging gaps across the CLL care pathway – Part 1: From Signal to Stratification

- 04/11/2025

Cracking the Multiple Myeloma Code: Why Systemic Change is Needed to Match Therapeutic Breakthroughs

- 21/10/2025

Where Technology Meets Human: A Call to Unite Clinical Expertise and Real‑World Patient Voices

- 20/10/2025

Unlocking the Future of Type 1 Diabetes Care: Why Earlier Diagnosis Must Match Innovation in Treatment

- 15/10/2025

Webinar: How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: a case study

- 05/09/2025

Optimising Rare Disease Clinical Trials with Real World Data Using NLP & AI: Volv Global at the Rare Trials Summit 2025

- 25/08/2025

Beyond Quick Fixes: How Predictive Modelling Can Redefine Clinical Trial Enrolment

- 21/08/2025

Beyond Initial Treatment: Navigating Recurrence Risk and Clinical Decisions in Cancer Survivors

- 08/07/2025